Core Viewpoint - The water quality testing instrument industry is experiencing steady growth driven by increasing public concern for water safety and stricter environmental regulations, with the market size projected to grow from 1.83 billion yuan in 2017 to 5.22 billion yuan by 2025, representing a compound annual growth rate (CAGR) of 14.03% [1][9]. Industry Overview - Water quality testing refers to the process of determining the types and concentrations of pollutants in water, evaluating water quality status [3]. - Key water quality indicators include comprehensive indicators (temperature, color, turbidity, pH, conductivity, suspended solids, dissolved oxygen, chemical oxygen demand, and biochemical oxygen demand) and toxic substances (phenols, cyanides, arsenic, lead, chromium, cadmium, mercury, and organic pesticides) [3]. - Water quality testing instruments can be categorized by function (single-parameter and multi-parameter testers), testing items (pH meters, total phosphorus testers, etc.), and usage environment (laboratory, portable, simple, and online testers) [4][3]. Market Demand and Growth - The market demand for water quality testing instruments is steadily increasing due to heightened public awareness and regulatory pressures [1][9]. - The industry is expected to play a crucial role in dynamic water quality monitoring, pollution warning, and comprehensive management, driven by advancements in smart, portable, and multi-parameter integrated technologies [1][9]. Industry Development Background - Water quality safety is a significant concern, with ongoing improvements in surface and groundwater quality in China [4][5]. - In 2024, 90.4% of monitored surface water quality sections were rated as good (Class I-III), indicating progress in water environment governance [5]. - Continuous, precise, and efficient monitoring of water quality is essential for ensuring environmental safety and supporting scientific decision-making [5]. Industry Chain - The upstream of the water quality testing instrument industry includes raw materials and components such as sensors, probes, circuit boards, optical components, and consumables [5]. - The midstream involves the production and manufacturing of water quality testing instruments, while the downstream encompasses sales channels and application fields, including environmental water, wastewater, and water conservancy sectors [5][6]. Competitive Landscape - The industry features a diverse competitive landscape with international leaders (e.g., Thermo Fisher, Hach, Siemens, ABB) dominating the high-end market, while domestic companies (e.g., Xuedilong, Xianhe Environmental Protection, and others) focus on mid-range markets and specialized applications [9][10]. - Domestic firms leverage their understanding of local markets and flexible service models to establish competitive advantages in mid-tier markets [10]. Key Companies - Xianhe Environmental Protection Technology Co., Ltd. has developed a comprehensive service provider model in environmental monitoring, with a reported revenue of 138 million yuan in the first half of 2025, reflecting a 0.73% year-on-year growth [10]. - Lihua Technology Co., Ltd. specializes in environmental monitoring systems, reporting a revenue of 558 million yuan in the first three quarters of 2025, marking a 5.15% increase [12]. Industry Trends - The industry is moving towards multi-parameter integration, real-time monitoring, and intelligent analysis, with future instruments expected to combine various detection technologies [13]. - There is a focus on miniaturization and rapid on-site detection capabilities, enabling water quality testing to expand into distributed scenarios such as river inspections and household water safety [14]. - Companies are transitioning from equipment suppliers to comprehensive solution providers, offering monitoring systems and data services, enhancing the value derived from long-term monitoring data [14].

Core Insights - The report emphasizes the strong growth potential in the testing services industry, particularly driven by emerging sectors such as commercial aerospace and new technologies [4][6] - The testing services sector is closely linked to macroeconomic growth, with a projected global market size of approximately 2.3 trillion RMB by 2024, reflecting a CAGR of about 6% from 2021 to 2024 [4][24] - In China, the testing services market is expected to reach around 487.6 billion RMB by 2024, with a CAGR of approximately 10.5% from 2015 to 2024, indicating a robust growth trajectory [5][24] Industry Overview - The testing, inspection, and certification (TIC) industry serves various sectors including consumer goods, industrial products, and pharmaceuticals, covering all stages from R&D to production and distribution [16][24] - The industry is characterized by a large market space and stable growth, with demand closely tied to macroeconomic trends and government regulations [20][24] - Emerging technologies such as AI, electric vehicles, and commercial aerospace are expected to create new testing demands, raising the entry barriers for new players [6][20] Company Performance - The report analyzes 19 listed companies in the testing services sector, highlighting their revenue and profit performance, with notable companies including Huace Testing, Guangdian Measurement, and Su Testing [2][11] - In the first three quarters of 2025, the testing services sector in China reported a revenue of 30.4 billion RMB, a decline of 7% year-on-year, but a growth of 3% when excluding companies heavily involved in medical testing [5][57] - Leading companies such as Huace Testing, Guangdian Measurement, and Su Testing demonstrated superior performance, with revenue growth rates of 7%, 12%, and 9% respectively, significantly outpacing the industry average [5][62] Market Dynamics - The testing services market is experiencing a structural shift, with a trend towards consolidation as larger firms gain market share and smaller firms face challenges [44][50] - The report notes that the majority of testing institutions in China are small and micro-sized, which limits their ability to withstand economic pressures [50][51] - Government policies are increasingly supporting the marketization and consolidation of testing institutions, aiming to enhance the overall quality and efficiency of the industry [51][53] Financial Metrics - The report indicates that the average gross margin for the testing services sector has improved, reaching 26.2% in the first three quarters of 2025, reflecting a recovery in profitability [63] - The accounts receivable turnover days have increased from 90 days in 2019 to 176 days in 2025, indicating a slowdown in cash flow and potential credit risks within the industry [67][68] - The report highlights that the proportion of accounts receivable in relation to revenue has risen to 50%, suggesting increasing challenges in managing receivables [71]

Investment Rating - The report recommends focusing on leading companies in the testing service industry, particularly those with strong capital, management, and research capabilities, such as Huace Testing, Guangdian Measurement, and Sutest [7] Core Insights - The testing service industry is closely related to macroeconomic growth, with significant market space and stable growth. The global testing service market is projected to reach approximately 2.3 trillion RMB by 2024, with a CAGR of about 6% from 2021 to 2024 [4][24] - China's testing service industry is expected to outpace GDP growth, with a projected market size of around 487.6 billion RMB in 2024, reflecting a CAGR of approximately 10.5% from 2015 to 2024 [5][24] - The industry is experiencing a structural shift, with emerging sectors such as AI, new energy vehicles, and commercial aerospace driving new demand for testing services [6][33] Summary by Sections Industry Overview - The testing, inspection, and certification (TIC) industry serves various sectors, including consumer goods, industrial products, and pharmaceuticals, covering all stages from R&D to production and distribution [16] - The demand for testing services is highly correlated with macroeconomic trends, with growth driven by global trade, increasing quality and safety standards, and stricter regulations [20][24] Market Performance - In 2025, the testing service sector in China reported revenues of 30.4 billion RMB, a year-on-year decline of 7%. Excluding companies with high medical testing proportions, the sector saw a 3% growth [5][57] - Leading companies like Huace Testing, Guangdian Measurement, and Sutest outperformed the industry average, with revenue growth rates of 7%, 12%, and 9% respectively in the first three quarters of 2025 [57][62] Emerging Opportunities - New technologies and industries, such as low-altitude economy and semiconductor sectors, are rapidly developing, creating new testing service demands. The investment threshold for laboratories in these areas is significantly higher than traditional sectors [6][33] - The report emphasizes the importance of focusing on leading companies that possess brand, capital, and management advantages to capitalize on these emerging opportunities [6][7] Competitive Landscape - The testing service market in China is characterized by a large number of small and medium-sized enterprises, with over 96% of testing institutions being micro-sized, which poses risks due to their limited capacity to withstand economic fluctuations [50][51] - The report predicts a trend towards consolidation in the industry, with resources increasingly concentrating in leading firms as smaller entities face challenges [50][51]

Group 1 - The company emphasizes its ability to leverage industry policy opportunities and has a comprehensive range of testing qualifications and extensive business layout, which supports solid business implementation and capacity release [2] - The company's operating performance has shown steady growth in recent years, with all operational data accurately reflecting its development achievements, countering claims of "paper data" [2] - As a leading enterprise in the industry, the company focuses on enhancing operational efficiency, accelerating the release of emerging businesses, and strengthening internal collaboration to create differentiated advantages [2] Group 2 - The company is successfully converting industry dividends into operational effectiveness and asserts that it does not underperform relative to the industry average [2] - The capital market performance is influenced by multiple factors, including macroeconomic conditions and market sentiment, and short-term fluctuations do not represent the company's long-term value [2] - The company encourages rational perspectives on market volatility and advises caution regarding investment risks [2]

Core Viewpoint - The company Huace Testing (300012) forecasts a net profit increase of 10%-11% for 2025, driven by successful overseas acquisitions, ongoing development in emerging businesses, and optimized corporate governance, amidst significant fluctuations in market capital flows [1][2]. Financial Performance - The company expects a net profit attributable to shareholders for 2025 to be between 1,012.77 million yuan and 1,021.49 million yuan, representing a year-on-year growth of 10%-11%. The fourth quarter is projected to see a net profit increase of 15%-20% [2]. Project Advancement - In the second half of 2025, the company completed acquisitions of SafetySA in South Africa, Emicert in Greece, and MIDAC laboratory in France, with successful integration into the company’s financials in the fourth quarter. However, the immediate contribution to earnings is limited, with long-term growth potential expected to gradually materialize [3]. Business Development - The company continues to focus on strategic areas such as semiconductor testing, low-altitude economy, and pharmaceutical testing. In semiconductor testing, it provides reliability validation services for AI computing chips, while in pharmaceutical testing, it is advancing technology reserves and qualification applications related to new viruses. These business segments are expected to increase their revenue share [4]. Corporate Structure and Governance - On December 25, 2025, the company completed a board of directors' election, with Wan Feng appointed as chairman. New committees, including a strategy and ESG committee, were established to enhance governance efficiency [5]. Capital Movements - Recent trading data indicates significant capital fluctuations, with a net outflow of 58.49 million yuan on January 20, 2026, and a further net outflow of 37.72 million yuan on January 26, 2026. These dynamics may reflect short-term market sentiment [6].

▶ 国家统计局：统计局：2025 年全年化妆品类零售额 4653 亿元，同比增长 5.1%。 出品方: 青眼情报 化妆品行业月报由青眼情报出品，每月 15 日发布。报告聚焦上一个月美妆行业动态， 内容涵盖中国美妆行业重大事件（包括本土及外资头部企业动态、渠道平台变革、产业园 及峰会等）、相关政策法规，以及行业资本事件（融资、并购、上市退市情况）、新品介 绍及新原料备案/注册情况，旨在为行业从业者提供全面及时的资讯参考。 一、 中国化妆品市场零售数据 中国化妆品市场月报（1 月) ► 朝云拟最高 4.5 亿元收购河北康达 100%股权，旨在进一步提升该集团在家 居护理品类在北方区域的市场竞争力。 ► 毛戈平与路威凯腾签订战略合作框架协议,双方将共同组建专注于全球高端 美妆领域的股权投资基金。 ► 锦波生物向养生堂定向发行股票的注册申请获批，本次发行股票的募资金额 不超过 20 亿元。 该战略投资落地，养生堂系将成为锦波生物第二大股东。 ► 中国化工企业天津利安隆集团在马来西亚投资约 21.7 亿元建设化妆品化工 研发中心及现代化生产工厂。 本土头部企业大事件 1. 投融资 ► 嘉亨家化控股股东曾本生向杭州拼便宜 ...

Investment Rating - The report maintains an "Outperform" rating for the industry, indicating a positive outlook compared to the broader market [3]. Core Insights - The low-altitude economy is poised for significant growth, supported by recent policy initiatives aimed at enhancing communication and navigation infrastructure [6][9]. - The report highlights the importance of integrating new technologies such as AI and big data into the low-altitude industry, which is expected to improve operational efficiency and safety [6][9]. - The government aims for a 90% coverage of ground mobile communication networks for low-altitude public air routes by 2027, indicating strong future demand for related technologies and services [6]. Summary by Sections Policy Developments - Multiple policies have been introduced since 2026 to support the low-altitude economy, including guidelines for establishing a standard system and enhancing infrastructure [8][10]. - The Shanghai and Shenzhen governments have set ambitious targets for the low-altitude economy, including a projected industry scale of 80 billion yuan by 2028 [8][10]. Investment Opportunities - Key companies to watch include: - **Suzhou Planning**: Plans to acquire Dongjin Aviation Technology, which specializes in air traffic management systems [14][16]. - **Brilliant Technology**: Engaged in eVTOL certification processes and has a strong order backlog, indicating robust growth potential [20][22]. - **Deep City Transportation**: Focused on low-altitude design consulting and infrastructure, with projects across multiple cities [24][26]. Market Trends - The number of registered drones in China is expected to reach 2.177 million by 2024, reflecting a 71.8% year-on-year increase, which underscores the rapid growth of the low-altitude sector [10][11]. - The number of general airports has increased to 475, indicating a growing infrastructure to support the low-altitude economy [12].

Core Viewpoint - The Biotech Index (970038) closed at 2196.51 points, up 0.05%, with a trading volume of 15.75 billion yuan and a turnover rate of 1.32% [1] Group 1: Index Performance - On the day, 20 stocks in the Biotech Index rose, with Furuimei leading at a 4.45% increase, while 28 stocks fell, with Aimeike leading the decline at 2.87% [1] - The net outflow of main funds from the Biotech Index constituents totaled 327 million yuan, while retail funds saw a net inflow of 162 million yuan [1] Group 2: Top Constituents - The top ten constituents of the Biotech Index include: - Mindray Medical (sz300760) with a weight of 13.73%, latest price of 190.36 yuan, and a market cap of 230.8 billion yuan [1] - Deep Technology (sz000021) with a weight of 5.05%, latest price of 28.69 yuan, and a market cap of 45.09 billion yuan [1] - Tigermed (sz300347) with a weight of 4.85%, latest price of 66.60 yuan, and a market cap of 57.34 billion yuan [1] - Other notable constituents include Changchun High-tech, Kanglong Chemical, and Yuyue Medical, all within the biotech sector [1] Group 3: Fund Flow Details - Detailed fund flow for selected stocks shows: - Kanglong Chemical (300759) had a main fund inflow of 10.6 million yuan, but retail funds saw a net outflow of 87.37 million yuan [2] - Furuimei (300049) experienced a main fund inflow of 63.48 million yuan, while retail funds had a net outflow of 64.28 million yuan [2] - Mindray Medical (300760) had a main fund inflow of 45.80 million yuan, with retail funds also experiencing a net outflow [2]

今年1月，国务院出台《固体废物综合治理行动计划》，提出到2030年重点领域固体废物专项整治取得 明显成效。国盛证券研报认为，固体废物治理要求按照减量化、资源化、无害化原则，构建覆盖源头减 量、过程管控、末端利用和无害化管理的综合治理体系，对固废处理等领域产生直接利好。 Wind数据显示，A股已有74家节能环保类上市公司披露2025年业绩预告。其中，45家公司净利润预计实 现同比增长（含18家预计减亏公司）。在绿色转型背景下，围绕能源管理、低碳园区服务的节能环保类 公司迎来发展机遇，部分资源再生公司通过市场拓展与技术创新实现业绩预增，一些公司通过提升运营 效率、优化管理实现降本增效。 把握绿色转型机遇 申菱环境预计2025年实现净利润2.05亿元—2.46亿元，较上年增长77.39%—122.87%。业绩增长的主要 原因是，数据中心建设持续加快，为公司数据服务业务带来较快增长；随着国家"碳中和"战略持续推 进，包括光伏发电、风力发电、抽水蓄能、新型储能、锂电池制造、充电桩等新能源相关产业将长期保 持快速发展，公司聚焦行业应用和高效节能，加强重点工业领域相关产品开发和业务拓展。 资源再生业务迎利好 在节能环保类上 ...

今年1月，国务院出台《固体废物 综合 治理行动计划》，提出到2030年重点领域固体废物专项整治取得 明显成效。 国盛证券 研报认为，固体废物治理要求按照减量化、资源化、无害化原则，构建覆盖源头 减量、过程管控、末端利用和无害化管理的综合治理体系，对 固废处理 等领域产生直接利好。 数据显示，A股已有74家 节能环保 类上市公司披露2025年业绩预告，其中45家公司净利润预计实现同 比增长（含18家预计减亏公司）。在绿色转型背景下，围绕能源管理、低碳园区服务的节能环保类公司 迎来发展机遇，部分资源再生公司通过市场拓展与技术创新实现业绩预增，一些公司通过提升运营效 率、优化管理实现降本增效。 把握绿色转型机遇 截至2月6日，在A股132家节能环保类上市公司中，已有74家公司披露2025年业绩预告。其中，31家公 司预告2025年净利润为正，在已披露公司中占比41.9%；45家公司预计净利润实现同比增长（含18家预 计减亏公司），占比60.8%。 南网能源 预计2025年净利润为3.0亿元至3.6亿元，上年净亏损为5812.6万元，业绩增长的主要原因是公 司节能业务板块巩固拓展，经营收入稳定增长；存量低效资产综合治 ...